Pexidartinib (Pex) for locally advanced tenosynovial giant cell tumour (TGCT): Characterization of hepatic adverse reactions (ARs)

Bauer, S; Lewis, JH; Gelderblom, H; van de Sande, M; Stacchiotti, S; Healey, JH; Tap, WD; Wagner, AJ; Pousa, AL; Druta, M; Lin, CC; Baba, HA; Yver, A; Shuster, DE; McGill, J; Gu, X; DeLeve, LD

ANNALS OF ONCOLOGY, 2019; 30 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索